eLaws | eCases | United States Code | Federal Courts |

Novo Nordisk Inc. - Comment

Document ID: FDA-2010-D-0529-0003
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: January 17 2011, at 12:00 AM Eastern Standard Time
Date Posted: January 18 2011, at 12:00 AM Eastern Standard Time
Comment Start Date: October 25 2010, at 12:00 AM Eastern Standard Time
Comment Due Date: January 24 2011, at 11:59 PM Eastern Standard Time
Tracking Number: 80bcc94b
View Document:

This is comment on Notice

Draft Guidance for Industry on Qualification Process for Drug Development Tools; Availability

View Comment

Please see attached comment letter

Attachments:

Novo Nordisk Inc. - Comment

Title:
Novo Nordisk Inc. - Comment

View Attachment:

View as format pdf

Related Comments

View All

Total: 15

Novo Nordisk Inc. - Comment
Public Submission Posted: 01/18/2011 ID: FDA-2010-D-0529-0003

Comment Period Closed
Jan 24,2011 11:59 PM ET

Amgen, Inc. - Comment
Public Submission Posted: 01/31/2011 ID: FDA-2010-D-0529-0007

Comment Period Closed
Jan 24,2011 11:59 PM ET

Bausch+Lomb - Comment
Public Submission Posted: 01/31/2011 ID: FDA-2010-D-0529-0008

Comment Period Closed
Jan 24,2011 11:59 PM ET

Quintiles - Comment
Public Submission Posted: 01/31/2011 ID: FDA-2010-D-0529-0009

Comment Period Closed
Jan 24,2011 11:59 PM ET

International Society for CNS Clinical Trials and Methodology (ISCTM) - Comment
Public Submission Posted: 01/31/2011 ID: FDA-2010-D-0529-0010

Comment Period Closed
Jan 24,2011 11:59 PM ET